hashimoto disease. Autoimmune thyroiditis
Conditions
Interventions
Intervention 1: Intervention group: received omega-3 supplement for 8 weeks 3 grams per day in three divided doses (one pill three times a day after meals) containing 180mg eicosapentaenoic acid and 1
Placebo
Intervention group: received omega-3 supplement for 8 weeks 3 grams per day in three divided doses (one pill three times a day after meals) containing 180mg eicosapentaenoic acid and 120mg docosahexae
Placebo group: took placebo pills containing edible paraffin 3 times in a day for 8 weeks
Sponsors
by my own
Eligibility
Sex/Gender
Female
Age
17 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Hashimoto patients over 18 years. Exclusion criteria: patients with rheumatoid arthritis; celiac disease; pernicious anemia; Systematic lupus erythematous and other autoimmune disease and other acute or chronic infections disease; postmenopausal women; pregnant and lactating women; taking drugs such as warfarin; aspirin; gamma interferon; smoking; using contraceptive drugs; Seasonal allergies; allergy to the fish or oil fish; eating fish over twice in week.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TNF-a (tumor necrosis factor alpha). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit.;ESR (erythrocyte sedimentation rate). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit.;Hs_CRP (high-sensitivity C-reactive protein). Timepoint: before and 8 week after intervention. Method of measurement: laboratory kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| 24 hour recall. Timepoint: before and 8 week after intervention. Method of measurement: 24 hour recall questioniare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Rasoul Zarrin
Urmia University of Medical Science
Outcome results
None listed